Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-20

FDA Approved: MACRILEN — Original Application (Aeterna Zentaris GmbH)

View source ↗

Summary

FDA approved MACRILEN (macimorelin acetate) from Aeterna Zentaris GmbH as an original application to diagnose adult growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MACRILEN (macimorelin acetate)

Snippet

ORIG AP for MACRILEN (MACIMORELIN ACETATE)